{"id":"https://openalex.org/W1986641043","doi":"https://doi.org/10.1002/(sici)1096-987x(19970715)18:9<1151::aid-jcc4>3.0.co;2-q","title":"Conformational analysis of HIV-1 protease inhibitors: 2. Thioproline P1? Residue in the potent inhibitor KNI-272","display_name":"Conformational analysis of HIV-1 protease inhibitors: 2. Thioproline P1? Residue in the potent inhibitor KNI-272","publication_year":1997,"publication_date":"1997-07-15","ids":{"openalex":"https://openalex.org/W1986641043","doi":"https://doi.org/10.1002/(sici)1096-987x(19970715)18:9<1151::aid-jcc4>3.0.co;2-q","mag":"1986641043"},"language":"en","primary_location":{"id":"doi:10.1002/(sici)1096-987x(19970715)18:9<1151::aid-jcc4>3.0.co;2-q","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1096-987x(19970715)18:9<1151::aid-jcc4>3.0.co;2-q","pdf_url":null,"source":{"id":"https://openalex.org/S21117631","display_name":"Journal of Computational Chemistry","issn_l":"0192-8651","issn":["0192-8651","1096-987X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Computational Chemistry","raw_type":"journal-article"},"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034115392","display_name":"Mark A. Murcko","orcid":"https://orcid.org/0000-0002-1235-2869"},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark A. Murcko","raw_affiliation_strings":["Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, Massachusetts 02139\u20134242"],"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, Massachusetts 02139\u20134242","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013793637","display_name":"B. Govinda Rao","orcid":null},"institutions":[{"id":"https://openalex.org/I61970326","display_name":"Vertex Pharmaceuticals (United States)","ror":"https://ror.org/00anb1726","country_code":"US","type":"company","lineage":["https://openalex.org/I61970326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Govinda Rao","raw_affiliation_strings":["Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, Massachusetts 02139\u20134242"],"affiliations":[{"raw_affiliation_string":"Vertex Pharmaceuticals, 130 Waverly Street, Cambridge, Massachusetts 02139\u20134242","institution_ids":["https://openalex.org/I61970326"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038644543","display_name":"Roberto Gomperts","orcid":null},"institutions":[{"id":"https://openalex.org/I61152923","display_name":"Cabot (United States)","ror":"https://ror.org/00ag9jk61","country_code":"US","type":"company","lineage":["https://openalex.org/I61152923"]},{"id":"https://openalex.org/I93085520","display_name":"Silicon Labs (United States)","ror":"https://ror.org/02dyqfb80","country_code":"US","type":"company","lineage":["https://openalex.org/I93085520"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Roberto Gomperts","raw_affiliation_strings":["Silicon Graphics, 1 Cabot Road, Hudson, Massachusetts 01749"],"affiliations":[{"raw_affiliation_string":"Silicon Graphics, 1 Cabot Road, Hudson, Massachusetts 01749","institution_ids":["https://openalex.org/I93085520","https://openalex.org/I61152923"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5034115392"],"corresponding_institution_ids":["https://openalex.org/I61970326"],"apc_list":{"value":4840,"currency":"USD","value_usd":4840},"apc_paid":null,"fwci":0.4318,"has_fulltext":false,"cited_by_count":6,"citation_normalized_percentile":{"value":0.60655067,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":94},"biblio":{"volume":"18","issue":"9","first_page":"1151","last_page":"1166"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9997000098228455,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9997000098228455,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.9988999962806702,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10911","display_name":"Chemical Synthesis and Analysis","score":0.9986000061035156,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/human-immunodeficiency-virus","display_name":"Human immunodeficiency virus (HIV)","score":0.5890955328941345},{"id":"https://openalex.org/keywords/chemistry","display_name":"Chemistry","score":0.5671798586845398},{"id":"https://openalex.org/keywords/residue","display_name":"Residue (chemistry)","score":0.5595808029174805},{"id":"https://openalex.org/keywords/protease","display_name":"Protease","score":0.5515984892845154},{"id":"https://openalex.org/keywords/protease-inhibitor","display_name":"Protease inhibitor (pharmacology)","score":0.45095694065093994},{"id":"https://openalex.org/keywords/pharmacology","display_name":"Pharmacology","score":0.37364882230758667},{"id":"https://openalex.org/keywords/biochemistry","display_name":"Biochemistry","score":0.35492855310440063},{"id":"https://openalex.org/keywords/enzyme","display_name":"Enzyme","score":0.3327176570892334},{"id":"https://openalex.org/keywords/virology","display_name":"Virology","score":0.32160794734954834},{"id":"https://openalex.org/keywords/biology","display_name":"Biology","score":0.25416460633277893},{"id":"https://openalex.org/keywords/antiretroviral-therapy","display_name":"Antiretroviral therapy","score":0.16900062561035156}],"concepts":[{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.5890955328941345},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5671798586845398},{"id":"https://openalex.org/C2781338088","wikidata":"https://www.wikidata.org/wiki/Q903495","display_name":"Residue (chemistry)","level":2,"score":0.5595808029174805},{"id":"https://openalex.org/C2776714187","wikidata":"https://www.wikidata.org/wiki/Q212410","display_name":"Protease","level":3,"score":0.5515984892845154},{"id":"https://openalex.org/C2781143361","wikidata":"https://www.wikidata.org/wiki/Q55761529","display_name":"Protease inhibitor (pharmacology)","level":5,"score":0.45095694065093994},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.37364882230758667},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.35492855310440063},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.3327176570892334},{"id":"https://openalex.org/C159047783","wikidata":"https://www.wikidata.org/wiki/Q7215","display_name":"Virology","level":1,"score":0.32160794734954834},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.25416460633277893},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.16900062561035156},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1002/(sici)1096-987x(19970715)18:9<1151::aid-jcc4>3.0.co;2-q","is_oa":false,"landing_page_url":"https://doi.org/10.1002/(sici)1096-987x(19970715)18:9<1151::aid-jcc4>3.0.co;2-q","pdf_url":null,"source":{"id":"https://openalex.org/S21117631","display_name":"Journal of Computational Chemistry","issn_l":"0192-8651","issn":["0192-8651","1096-987X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Computational Chemistry","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/6","score":0.5,"display_name":"Clean water and sanitation"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W1480478945","https://openalex.org/W1574312817","https://openalex.org/W1966041739","https://openalex.org/W1966952510","https://openalex.org/W1981491253","https://openalex.org/W1983066351","https://openalex.org/W2003027607","https://openalex.org/W2011613928","https://openalex.org/W2019691224","https://openalex.org/W2027189612","https://openalex.org/W2029481593","https://openalex.org/W2038350697","https://openalex.org/W2042073740","https://openalex.org/W2075014527","https://openalex.org/W2075987068","https://openalex.org/W2094133126","https://openalex.org/W2094600579","https://openalex.org/W2113403117","https://openalex.org/W2123166384","https://openalex.org/W2136371489","https://openalex.org/W2139356960","https://openalex.org/W2141385111","https://openalex.org/W2148526417","https://openalex.org/W2160276605","https://openalex.org/W2162166182","https://openalex.org/W2326484947"],"related_works":["https://openalex.org/W2947721917","https://openalex.org/W2781122945","https://openalex.org/W4230319148","https://openalex.org/W2091035713","https://openalex.org/W1986564937","https://openalex.org/W2402288054","https://openalex.org/W2178059071","https://openalex.org/W2120338717","https://openalex.org/W2020436890","https://openalex.org/W1245749104"],"abstract_inverted_index":{"The":[0,14,35,300],"very":[1],"potent":[2],"HIV-1":[3],"protease":[4,229],"(HIV-PR)":[5],"inhibitor,":[6],"KNI-272,":[7,303],"contains":[8],"a":[9,39,97,107,166,170,237,241,246,279],"norstatine\u2013thioproline":[10,71,102,146,200],"linkage":[11,104,148,275],"at":[12,186],"P1\u2013P1\u2032.":[13],"three-dimensional":[15],"crystal":[16,36],"structure":[17,37],"of":[18,41,65,69,73,81,88,93,125,144,161,177,198,213,257,261,268],"this":[19],"compound":[20],"bound":[21,47,67,156,259],"to":[22,60,105,180,189,210,239,244,250,293],"HIV-PR":[23,48],"has":[24,165],"recently":[25],"been":[26],"determined":[27],"[Baldwin":[28],"et":[29,76],"al.,":[30],"Structure,":[31],"3,":[32],"581":[33],"(1995)].":[34],"reveals":[38],"number":[40],"interesting":[42],"interactions":[43],"previously":[44,224],"unseen":[45],"in":[46,122,130,135,152,157,298],"inhibitors.":[49],"Here,":[50],"we":[51],"employ":[52],"high-level":[53],"ab":[54],"initio":[55],"calculations":[56],"and":[57,96,134,141,285,306],"molecular":[58],"modeling":[59],"ascertain":[61],"the":[62,66,70,82,85,91,101,115,123,126,131,145,158,175,181,193,199,211,214,227,251,255,258,273],"strain":[63,256],"energy":[64],"conformation":[68,197,260],"portion":[72],"KNI-272.":[74],"Baldwin":[75],"al.":[77],"suggested":[78],"that":[79,192,267],"two":[80],"reasons":[83],"for":[84,100,169,226,287],"high":[86],"potency":[87],"KNI-272":[89,163,262],"are":[90,138,150],"rigidity":[92],"its":[94],"backbone":[95,124],"strong":[98,167],"preference":[99,168],"amide":[103,147,196],"adopt":[106,240],"trans":[108,142,171,195],"conformation.":[109],"Our":[110,184],"analysis":[111],"shows":[112],"that,":[113],"on":[114],"contrary,":[116],"there":[117,137],"is":[118,202,220,263,311],"still":[119,203],"considerable":[120],"flexibility":[121],"norstatine-based":[127],"inhibitor.":[128],"Furthermore,":[129],"gas":[132],"phase":[133],"solution,":[136],"both":[139],"cis":[140],"conformations":[143],"which":[149,173,234,295],"low":[151],"energy.":[153],"However,":[154,254],"when":[155],"active":[159],"site":[160],"HIV-PR,":[162],"clearly":[164,264],"conformation,":[172],"enables":[174],"formation":[176],"hydrogen":[178,248],"bonds":[179],"flap":[182,252],"water.":[183,253],"calculations,":[185],"level":[187],"up":[188],"MP2/6-31++G//HF/6-31G*,":[190],"suggest":[191],"bound,":[194],"\u201ccore\u201d":[201],"strained":[204],"by":[205],"2\u20133":[206],"kcal/mol,":[207],"primarily":[208],"due":[209],"placement":[212],"P1\u2032":[215,307],"thioproline":[216],"carboxamide.":[217],"This":[218],"result":[219],"consistent":[221],"with":[222],"those":[223],"obtained":[225],"related":[228],"inhibitor":[230],"Ro":[231],"31-8959":[232],"(Saquinovir),":[233],"also":[235,296,310],"requires":[236],"carboxamide":[238],"high-energy":[242],"rotamer":[243],"preserve":[245],"good":[247],"bond":[249],"lower":[265],"than":[266],"Saquinovir.":[269],"In":[270],"addition,":[271],"because":[272],"norstatine":[274],"does":[276],"not":[277],"contain":[278],"basic":[280],"amine":[281],"(as":[282],"do":[283],"Saquinovir":[284],"JG-365,":[286,304],"example)":[288],"it":[289],"should":[290],"be":[291],"easier":[292],"desolvate,":[294],"assists":[297],"binding.":[299],"relationship":[301],"between":[302],"Saquinovir,":[305],"proline-containing":[308],"substrate":[309],"discussed.":[312],"\u00a9":[313],"1997":[314],"John":[315],"Wiley":[316],"&":[317],"Sons,":[318],"Inc.":[319],"J":[320],"Comput":[321],"Chem":[322],"18:":[323],"1151\u20131166":[324]},"counts_by_year":[{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1}],"updated_date":"2025-11-06T03:46:38.306776","created_date":"2025-10-10T00:00:00"}